Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.
| Image |  |
|---|---|
| Description | scientific article published on 25 March 2018 |
| Author/s |
author: Emilande Guichet Guillaume Bado Sabrina Eymard-Duvernay Sinata Koulla-Shiro Christian Julián Villabona-Arenas Laura Ciaffi Coumba Touré Kane Martine Peeters Eric Delaporte Avelin F. Aghokeng |
| Publication date | March 25, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |